Rating History for Alterity Therapeutics (ATHE) by Benchmark

More Stocks Rated by Benchmark | Latest Ratings for ATHE
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
2/3/2025 Bob Wasserman New Coverage Speculative Buy
(N/A)		 N/A
(N/A)		 4.80
(3.43)		 -28.54% Details